Your Advocates Ltd’s Cytosorbents Corp CTSO Stock Holding History

Your Advocates Ltd’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$143	Hold	250	–	–	﹤0.01%	216
2025 Q4	$160	Hold	250	–	–	﹤0.01%	220
2025 Q3	$233	Hold	250	–	–	﹤0.01%	203
2025 Q2	$320	Hold	250	–	–	﹤0.01%	182
2025 Q1	$250	Hold	250	–	–	﹤0.01%	191
2024 Q4	$228	Hold	250	–	–	﹤0.01%	194
2024 Q3	$375	Hold	250	–	–	﹤0.01%	210
2024 Q2	$175	Hold	250	–	–	﹤0.01%	219
2024 Q1	$238	Hold	250	–	–	﹤0.01%	213
2023 Q4	$278	Hold	250	–	–	﹤0.01%	218
2023 Q3	$470	Hold	250	–	–	﹤0.01%	244
2023 Q2	$898	Hold	250	–	–	﹤0.01%	238
2023 Q1	$843	Hold	250	–	–	﹤0.01%	204
2022 Q4	$388	Hold	250	–	–	﹤0.01%	202
2022 Q3	$0	Hold	250	–	–	﹤0.01%	204
2022 Q2	$1K	Hold	250	–	–	﹤0.01%	180
2022 Q1	$1K	Hold	250	–	–	﹤0.01%	200
2021 Q4	$1K	Hold	250	–	–	﹤0.01%	186
2021 Q3	$2K	Hold	250	–	–	﹤0.01%	166
2021 Q2	$2K	Hold	250	–	–	﹤0.01%	124
2021 Q1	$2K	Buy	+250	New	+$2.38K	﹤0.01%	121

Other funds holding CTSO

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Your Advocates Ltd's CTSO Position: Q1 2026 in Review

Your Advocates Ltd held its Cytosorbents Corp (CTSO) position steady in Q1 2026 at 250 shares worth $143. The position accounts for ﹤0.01% of the portfolio, ranked #216.

Your Advocates Ltd first reported a position in CTSO in Q1 2021 and has held it in 21 quarters since. The position peaked at $2K in Q3 2021. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

Your Advocates Ltd held 250 shares of Cytosorbents Corp worth $143 as of Q1 2026.
Your Advocates Ltd left its Cytosorbents Corp share count unchanged in Q1 2026.
Cytosorbents Corp made up ﹤0.01% of Your Advocates Ltd's portfolio in Q1 2026, its #216 holding.
Your Advocates Ltd first reported a position in Cytosorbents Corp in Q1 2021 and has held it in 21 quarters since.
Your Advocates Ltd's Cytosorbents Corp position peaked at $2K in Q3 2021.
50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on Your Advocates Ltd's 13F filing for Q1 2026, filed 30 Apr 2026.